CD74 Polyclonal Antibody (AN006060L)
For research use only.
| Verified Samples | Verified Samples in IHC: Human tonsil, Human lung cancer, Human breast cancer |
| Dilution | IHC 1:50-1:100 |
| Isotype | IgG |
| Host | Rabbit |
| Reactivity | Human |
| Applications | IHC |
| Clonality | Polyclonal |
| Immunogen | Recombinant Human CD74 protein expressed by E.coli |
| Abbre | CD74 |
| Synonyms | CD 74, CD74 antigen, CD74 antigen (invariant polypeptide of major histocompatibility complex, CD74 molecule, class II antigen-associated), class II invariant chain, CLIP, Gamma chain of class II antigens, HG2A, HLA DR antigens associated invariant chain, HLA DR gamma, HLADR antigens associated invariant chain, HLA-DR antigens-associated invariant chain, HLA-DR-gamma, Ia antigen associated invariant chain, Ia associated invariant chain, Ia gamma, Ia-GAMMA, Invariant polypeptide of major histocompatibility complex class II antigen associated, la-gamma, major histocompatibility complex, Major histocompatibility complex class II invariant chain, MHC HLA DR gamma chain, MHC HLA-DR gamma chain, p35, Protein 41, CD74, DHLAG, HLA class II histocompatibility antigen gamma chain, HLADG, Ia antigen-associated invariant chain, p33, CD 14, CD_antigen=CD14, CD14, CD14 antigen, CD14 molecule, LPS-R, Mo2, Monocyte differentiation antigen CD14, Monocyte differentiation antigen CD14 urinary form, membrane-bound form, Myeloid cell specific leucine rich glycoprotein, Myeloid cell-specific leucine-rich glycoprotein, HLA class II histocompatibility antigen gamma chain, HLADG, Ia antigen-associated invariant chain, Ia-GAMMA II, Ii, p33, CD74 HLA-DR antigens-associated invariant chain, DHLAG, CD74, invariant chain |
| Swissprot | |
| Cellular Localization | Cell membrane, Endosome, Lysosome, Secreted |
| Tissue Specificity | Detected in urine (at protein level). |
| Concentration | 1 mg/mL |
| Buffer | PBS with 0.05% proclin 300, 1% protective protein and 50% glycerol,pH7.4 |
| Purification Method | Antigen Affinity Purification |
| Research Areas | Immunology |
| Conjugation | Unconjugated |
| Storage | Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles. |
| Shipping | The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended. |
| background | Plays a critical role in MHC class II antigen processing by stabilizing peptide-free class II alpha/beta heterodimers in a complex soon after their synthesis and directing transport of the complex from the endoplasmic reticulum to the endosomal/lysosomal system where the antigen processing and binding of antigenic peptides to MHC class II takes place. Serves as cell surface receptor for the cytokine MIF. Class-II-associated invariant chain peptide Binds to the peptide-binding site of MHC class II alpha/beta heterodimers forming an alpha-beta-CLIP complex, thereby preventing the loading of antigenic peptides to the MHC class II complex until its release by HLA-DM in the endosome.1 Publication Isoform p41 Stabilizes the conformation of mature CTSL by binding to its active site and serving as a chaperone to help maintain a pool of mature enzyme in endocytic compartments and extracellular space of antigen-presenting cells (APCs). Has antiviral activity by stymieing the endosomal entry of Ebola virus and coronaviruses, including SARS-CoV-2. Disrupts cathepsin-mediated Ebola virus glycoprotein processing, which prevents viral fusion and entry. This antiviral activity is specific to p41 isoform. |
Other Clones
{{antibodyDetailsPage.numTotal}} Results
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.：{{item.cat}}
{{index}} {{goods_show_value}}
Other Formats
{{formatDetailsPage.numTotal}} Results
Unconjugated
-
{{item.title}}
Citations ({{item.publications_count}}) Manual MSDS
Cat.No.：{{item.cat}}
{{index}} {{goods_show_value}}
-
IF：{{item.impact}}
Journal：{{item.journal}} ({{item.year}})
DOI：{{item.doi}}Reactivity：{{item.species}}
Sample Type：{{item.organization}}
-
Q{{(FAQpage.currentPage - 1)*pageSize+index+1}}:{{item.name}}
